CoChat

Age-dependent functional crosstalk between cardiac fibroblasts and cardiomyocytes in a 3D engineered cardiac tissue

Open access
Li, Yanzhen, Asfour, Huda, Bursac, Nenad · 2017 · Acta Biomaterialia
Cited by 95

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Complex heterocellular interactions between cardiomyocytes and fibroblasts in the heart involve their bidirectional signaling via cell-cell contacts, paracrine factors, and extracellular matrix (ECM). These interactions vary with heart development and pathology leading to changes in cardiac structure and function. Whether cardiac fibroblasts of different ages interact differentially with cardiomyocytes to distinctly impact their function remains unknown. Here, we explored the direct structural and functional effects of fetal and adult cardiac fibroblasts on cardiomyocytes using a tissue-engineered 3D co-culture system. We show that the age of cardiac fibroblasts is a strong determinant of the structure, function, and molecular properties of co-cultured tissues. In particular, in vitro expanded adult, but not fetal, cardiac fibroblasts significantly deteriorated electrical and mechanical function of the co-cultured cardiomyocytes, as evidenced by slower action potential conduction, prolonged action potential duration, weaker contractions, higher tissue stiffness, and reduced calcium transient amplitude. This functional deficit was associated with structural and molecular signatures of pathological remodeling including fibroblast proliferation, interstitial collagen deposition, and upregulation of pro-fibrotic markers. Our studies imply critical roles of the age of supporting cells in engineering functional cardiac tissues and provide a new physiologically relevant in vitro platform to investigate influence of heterocellular interactions on cardiomyocyte function, development, and disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.actbio.2017.04.027

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 66

  1. Bursac, 2014, Cardiac fibroblasts in pressure overload hypertrophy: the enemy within?, J Clin Invest, 124, 2850, 10.1172/JCI76628 · DOI
  2. Furtado, 2016, View from the heart: cardiac fibroblasts in development, scarring and regeneration, Development, 143, 387, 10.1242/dev.120576 · DOI · Paper page
  3. Gourdie, 2016, Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease, Nat Rev Drug Discov, 10.1038/nrd.2016.89 · DOI · Paper page
  4. Nag, 1980, Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution, Cytobios, 28, 41
  5. Bergmann, 2015, Dynamics of cell generation and turnover in the human heart, Cell, 161, 1566, 10.1016/j.cell.2015.05.026 · DOI · Paper page
  6. Banerjee, 2007, Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse, Am J Physiol Heart Circ Physiol, 293, H1883, 10.1152/ajpheart.00514.2007 · DOI · Paper page
  7. Souders, 2012, Pressure overload induces early morphological changes in the heart, Am J Pathol, 181, 1226, 10.1016/j.ajpath.2012.06.015 · DOI · Paper page
  8. Camelliti, 2005, Structural and functional characterisation of cardiac fibroblasts, Cardiovasc Res, 65, 40, 10.1016/j.cardiores.2004.08.020 · DOI · Paper page
  9. Kohl, 2014, Fibroblast-myocyte electrotonic coupling: does it occur in native cardiac tissue?, J Mol Cell Cardiol, 70, 37, 10.1016/j.yjmcc.2013.12.024 · DOI · Paper page
  10. Porter, 2009, Cardiac fibroblasts: at the heart of myocardial remodeling, Pharmacol Ther, 123, 255, 10.1016/j.pharmthera.2009.05.002 · DOI · Paper page
  11. Zhang, 2012, Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences, Am J Physiol Heart Circ Physiol, 303, H1385, 10.1152/ajpheart.01167.2011 · DOI
  12. Ogle, 2016, Distilling complexity to advance cardiac tissue engineering, Sci Transl Med, 8, 342ps313, 10.1126/scitranslmed.aad2304 · DOI · Paper page
  13. Cartledge, 2015, Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators, Cardiovasc Res, 105, 260, 10.1093/cvr/cvu264 · DOI · Paper page
  14. Yue, 2011, Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation, Cardiovasc Res, 89, 744, 10.1093/cvr/cvq329 · DOI · Paper page
  15. Vasquez, 2010, Enhanced fibroblast-myocyte interactions in response to cardiac injury, Circ Res, 107, 1011, 10.1161/CIRCRESAHA.110.227421 · DOI · Paper page
  16. Pedrotty, 2009, Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes, Cardiovasc Res, 83, 688, 10.1093/cvr/cvp164 · DOI · Paper page
  17. Zlochiver, 2008, Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers, Biophys J, 95, 4469, 10.1529/biophysj.108.136473 · DOI · Paper page
  18. Miragoli, 2007, Myofibroblasts induce ectopic activity in cardiac tissue, Circ Res, 101, 755, 10.1161/CIRCRESAHA.107.160549 · DOI · Paper page
  19. Gaudesius, 2003, Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin, Circ Res, 93, 421, 10.1161/01.RES.0000089258.40661.0C · DOI · Paper page
  20. Abbott, 2003, Cell culture: biology's new dimension, Nature, 424, 870, 10.1038/424870a · DOI · Paper page
  21. Gerecht-Nir, 2006, Biophysical regulation during cardiac development and application to tissue engineering, Int J Dev Biol, 50, 233, 10.1387/ijdb.052041sg · DOI
  22. Hirt, 2014, Cardiac tissue engineering: state of the art, Circ Res, 114, 354, 10.1161/CIRCRESAHA.114.300522 · DOI · Paper page
  23. Griffith, 2006, Capturing complex 3D tissue physiology in vitro, Nat Rev Mol Cell Biol, 7, 211, 10.1038/nrm1858 · DOI · Paper page
  24. Kurokawa, 2016, Tissue engineering the cardiac microenvironment: multicellular microphysiological systems for drug screening, Adv Drug Deliv Rev, 96, 225, 10.1016/j.addr.2015.07.004 · DOI · Paper page
  25. Ieda, 2009, Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling, Dev Cell, 16, 233, 10.1016/j.devcel.2008.12.007 · DOI · Paper page
  26. Jackman, 2016, Dynamic culture yields engineered myocardium with near-adult functional output, Biomaterials, 111, 66, 10.1016/j.biomaterials.2016.09.024 · DOI · Paper page
  27. Bursac, 1999, Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies, Am J Physiol, 277, H433
  28. Bian, 2009, Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues, Nat Protoc, 4, 1522, 10.1038/nprot.2009.155 · DOI · Paper page
  29. Zhang, 2013, Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes, Biomaterials, 34, 5813, 10.1016/j.biomaterials.2013.04.026 · DOI · Paper page
  30. Madden, 2015, Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs, eLife, 4, e04885, 10.7554/eLife.04885 · DOI · Paper page
  31. Liau, 2011, Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function, Biomaterials, 32, 9180, 10.1016/j.biomaterials.2011.08.050 · DOI · Paper page
  32. Nguyen, 2016, Engineering prokaryotic channels for control of mammalian tissue excitability, Nat Commun, 7, 13132, 10.1038/ncomms13132 · DOI
  33. Kirkton, 2011, Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies, Nat Commun, 2, 300, 10.1038/ncomms1302 · DOI
  34. Juhas, 2014, Roles of adherent myogenic cells and dynamic culture in engineered muscle function and maintenance of satellite cells, Biomaterials, 35, 9438, 10.1016/j.biomaterials.2014.07.035 · DOI
  35. Christoforou, 2013, Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues, PLoS One, 8, e65963, 10.1371/journal.pone.0065963 · DOI
  36. Lin, 2011, A method to measure myocardial calcium handling in adult Drosophila, Circ Res, 108, 1306, 10.1161/CIRCRESAHA.110.238105 · DOI
  37. Zhang, 2015, STIM1-Ca2+ signaling modulates automaticity of the mouse sinoatrial node, Proc Natl Acad Sci U S A, 112, E5618, 10.1073/pnas.1503847112 · DOI
  38. Liau, 2012, Functional cardiac tissue engineering, Regen Med, 7, 187, 10.2217/rme.11.122 · DOI · Paper page
  39. Kanisicak, 2016, Genetic lineage tracing defines myofibroblast origin and function in the injured heart, Nat Commun, 7, 12260, 10.1038/ncomms12260 · DOI · Paper page
  40. Kaur, 2016, Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice, Circ Res, 118, 1906, 10.1161/CIRCRESAHA.116.308643 · DOI · Paper page
  41. Moore-Morris, 2016, Origins of cardiac fibroblasts, J Mol Cell Cardiol, 91, 1, 10.1016/j.yjmcc.2015.12.031 · DOI · Paper page
  42. Zeisberg, 2010, Origins of cardiac fibroblasts, Circ Res, 107, 1304, 10.1161/CIRCRESAHA.110.231910 · DOI · Paper page
  43. Xi, 2011, Fibroblasts support functional integration of purified embryonic stem cell-derived cardiomyocytes into avital myocardial tissue, Stem Cells Dev, 20, 821, 10.1089/scd.2010.0398 · DOI
  44. Matsuura, 2011, Creation of mouse embryonic stem cell-derived cardiac cell sheets, Biomaterials, 32, 7355, 10.1016/j.biomaterials.2011.05.042 · DOI
  45. Pfannkuche, 2010, Fibroblasts facilitate the engraftment of embryonic stem cell-derived cardiomyocytes on three-dimensional collagen matrices and aggregation in hanging drops, Stem Cells Dev, 19, 1589, 10.1089/scd.2009.0255 · DOI
  46. Furtado, 2014, Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair, Circ Res, 114, 1422, 10.1161/CIRCRESAHA.114.302530 · DOI · Paper page
  47. Tirziu, 2010, Cell communications in the heart, Circulation, 122, 928, 10.1161/CIRCULATIONAHA.108.847731 · DOI · Paper page
  48. Takeda, 2011, Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling, Int J Inflam, 2011, 535241
  49. Williams, 2014, Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro, Acta Biomater., 10, 194, 10.1016/j.actbio.2013.08.037 · DOI · Paper page
  50. Chen, 1833, Fibroblasts in post-infarction inflammation and cardiac repair, Biochim Biophys Acta, 2013, 945
  51. Baum, 2011, Fibroblasts and myofibroblasts: what are we talking about?, J Cardiovasc Pharmacol, 57, 376, 10.1097/FJC.0b013e3182116e39 · DOI · Paper page
  52. Souders, 2009, Cardiac fibroblast: the renaissance cell, Circ Res, 105, 1164, 10.1161/CIRCRESAHA.109.209809 · DOI · Paper page
  53. Leslie, 1991, Cardiac myofibroblasts express alpha smooth muscle actin during right ventricular pressure overload in the rabbit, Am J Pathol, 139, 207
  54. Rohr, 2011, Cardiac fibroblasts in cell culture systems: myofibroblasts all along?, J Cardiovasc Pharmacol, 57, 389, 10.1097/FJC.0b013e3182137e17 · DOI · Paper page
  55. Dawson, 2012, Congestive heart failure effects on atrial fibroblast phenotype: Differences between freshly-isolated and cultured cells, PLoS One, 7, e52032, 10.1371/journal.pone.0052032 · doi:10.1371/journal.pone.0052032
  56. Kaur, 2016, Targeted ablation of periostin-expressing activated fibroblasts prevents adverse cardiac remodeling in mice, Circ Res, 10.1161/CIRCRESAHA.116.308643 · DOI · Paper page
  57. Biernacka, 2011, Aging and Cardiac Fibrosis, Aging Dis, 2, 158
  58. Kong, 2014, The pathogenesis of cardiac fibrosis, Cell Mol Life Sci, 71, 549, 10.1007/s00018-013-1349-6 · DOI · Paper page
  59. Horn, 2016, Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling, J Mol Cell Cardiol, 93, 175, 10.1016/j.yjmcc.2015.11.005 · DOI · Paper page
  60. McSpadden, 2012, Size and ionic currents of unexcitable cells coupled to cardiomyocytes distinctly modulate cardiac action potential shape and pacemaking activity in micropatterned cell pairs, Circ. Arrhythm Electrophysiol, 5, 821, 10.1161/CIRCEP.111.969329 · DOI
  61. Shadrin, 2016, Striated muscle function, regeneration, and repair, Cell Mol Life Sci, 73, 4175, 10.1007/s00018-016-2285-z · DOI
  62. Kizana, 2006, Fibroblasts modulate cardiomyocyte excitability: implications for cardiac gene therapy, Gene Ther, 13, 1611, 10.1038/sj.gt.3302813 · DOI
  63. Oka, 2007, Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling, Circ Res, 101, 313, 10.1161/CIRCRESAHA.107.149047 · DOI · Paper page
  64. Mohamed, 2016, The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy, Nat Commun, 7, 11074, 10.1038/ncomms11074 · DOI
  65. Pijnappels, 2007, Resynchronization of separated rat cardiomyocyte fields with genetically modified human ventricular scar fibroblasts, Circulation, 116, 2018, 10.1161/CIRCULATIONAHA.107.712935 · DOI
  66. Engels, 2015, Forced fusion of human ventricular scar cells with cardiomyocytes suppresses arrhythmogenicity in a co-culture model, Cardiovasc Res, 107, 601, 10.1093/cvr/cvv191 · DOI

Cited by

Metadata

Authors
Li, Y., Asfour, H., & Bursac, N.
Venue
Acta Biomaterialia
Publisher
Elsevier BV
Published
2017-06
Volume
55
Pages
120-130
ISSN
1742-7061 (ISSN-L)
OpenAlex
W2607645184
Cited by
95
References
12
FWCI
6.89
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Institutes of Health
  • Duke (HL104326, HL126524, HL132389, HL134764)
  • American Heart Association

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.